Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

40 (error)

Events

first seen date

2023-12-21 18:55:00

expired found date

-

created at

2024-06-08 02:55:47

updated at

2025-12-31 19:19:12

Domain name statistics

length

17

crc

12248

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

173561409

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

132448

mp size raw text

9439

mp inner links count

10

mp inner links status

20 (imported)

Open Graph

title

Pharma in Brief

description

Pharma in Brief is written by Norton Rose Fulbright litigation and regulatory lawyers covering topics such as patent and class action disputes, drug advertising & reimbursement, and compliance with He

site name

Pharma in Brief

author

updated

2025-12-20 01:48:42

raw text

Pharma in Brief | Norton Rose Fulbright LLP | Pharmaceuticals & Life Sciences Updates New Canadian Drug Agency formed, while National Pharmacare bill is delayed into 2024 By Christopher A. Guerreiro , Paul Jorgensen and Kristin Wall on December 20, 2023 Posted in Life sciences and healthcare, Pharmaceuticals and life sciences The Government of Canada has announced the creation of the Canadian Drug Agency (CDA). According to the government, the CDA “will provide the dedicated leadership and coordination needed to make Canada’s drug system more sustainable and better prepared for the future, helping Canadians achieve better health outcomes.” As we reported, the genesis of the CDA … Continue reading Tweet this post Like this post Email this post Share this post on LinkedIn Tags: Health Canada, Regulatory Federal Court refuses to issue injunction on infringed antibody formulation patent By Paul Jorgensen , Christopher A. Guerreiro and Brian R. Daley...

Text analysis

redirect type

31 (document.location)

block type

0 (no issues)

detected language

1 (English)

category id

Prawo (24)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

7472

text words

1347

text unique words

458

text lines

241

text sentences

42

text paragraphs

10

text words per sentence

32

text matched phrases

11

text matched dictionaries

6

RSS

rss status

32 (unknown)

rss found date

2023-12-26 19:43:29

rss size orig

71592

rss items

10

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

314

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-01-08 08:47:58

sitemap process date

2024-08-30 16:06:20

sitemap first import date

-

sitemap last import date

-